1. Home
  2. LQDA vs ACMR Comparison

LQDA vs ACMR Comparison

Compare LQDA & ACMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LQDA
  • ACMR
  • Stock Information
  • Founded
  • LQDA 2004
  • ACMR 1998
  • Country
  • LQDA United States
  • ACMR United States
  • Employees
  • LQDA N/A
  • ACMR N/A
  • Industry
  • LQDA Biotechnology: Pharmaceutical Preparations
  • ACMR Industrial Machinery/Components
  • Sector
  • LQDA Health Care
  • ACMR Technology
  • Exchange
  • LQDA Nasdaq
  • ACMR Nasdaq
  • Market Cap
  • LQDA 1.2B
  • ACMR 1.3B
  • IPO Year
  • LQDA 2018
  • ACMR 2017
  • Fundamental
  • Price
  • LQDA $19.60
  • ACMR $29.93
  • Analyst Decision
  • LQDA Strong Buy
  • ACMR Buy
  • Analyst Count
  • LQDA 9
  • ACMR 5
  • Target Price
  • LQDA $27.67
  • ACMR $30.50
  • AVG Volume (30 Days)
  • LQDA 2.4M
  • ACMR 863.3K
  • Earning Date
  • LQDA 08-06-2025
  • ACMR 08-06-2025
  • Dividend Yield
  • LQDA N/A
  • ACMR N/A
  • EPS Growth
  • LQDA N/A
  • ACMR 19.75
  • EPS
  • LQDA N/A
  • ACMR 1.57
  • Revenue
  • LQDA $14,144,000.00
  • ACMR $802,274,000.00
  • Revenue This Year
  • LQDA $189.27
  • ACMR $19.19
  • Revenue Next Year
  • LQDA $402.79
  • ACMR $15.21
  • P/E Ratio
  • LQDA N/A
  • ACMR $19.04
  • Revenue Growth
  • LQDA N/A
  • ACMR 26.21
  • 52 Week Low
  • LQDA $8.26
  • ACMR $13.87
  • 52 Week High
  • LQDA $19.76
  • ACMR $30.73
  • Technical
  • Relative Strength Index (RSI)
  • LQDA 79.39
  • ACMR 64.87
  • Support Level
  • LQDA $14.04
  • ACMR $29.00
  • Resistance Level
  • LQDA $14.67
  • ACMR $30.54
  • Average True Range (ATR)
  • LQDA 0.89
  • ACMR 0.97
  • MACD
  • LQDA 0.70
  • ACMR -0.07
  • Stochastic Oscillator
  • LQDA 97.88
  • ACMR 72.41

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

About ACMR ACM Research Inc.

ACM Research Inc supplies advanced, innovative capital equipment developed for the global semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.

Share on Social Networks: